Dr. Reddy's Laboratories has been granted approval by the Drugs Controller General of India (DCGI) for Zytorvi (toripalimab) in India. The drug is meant for patients with advanced esophageal squamous cell carcinoma (ESCC). ESCC is a form of esophageal cancer that arises in the squamous cells forming the inner lining of the esophagus, the food pipe. The approval allows the company to offer this treatment option for the advanced stage of the disease in the country.